Lowering plasma cholesterol levels halts progression of aortic valve disease in mice

Jordan D Miller, Robert M. Weiss, Kristine M. Serrano, Robert M. Brooks, Christopher J. Berry, Kathy Zimmerman, Stephen G. Young, Donald D. Heistad

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

BACKGROUND-: Treatment of hyperlipidemia produces functional and structural improvements in atherosclerotic vessels. However, the effects of treating hyperlipidemia on the structure and function of the aortic valve have been controversial, and any effects could be confounded by pleiotropic effects of hypolipidemic treatment. The goal of this study was to determine whether reducing elevated plasma lipid levels with a "genetic switch" in Reversa mice (Ldlr-/-/Apob/Mttp/Mx1-Cre) reduces oxidative stress, reduces pro-osteogenic signaling, and retards the progression of aortic valve disease. METHODS AND RESULTS-: After 6 months of hypercholesterolemia, Reversa mice exhibited increases in superoxide, lipid deposition, myofibroblast activation, calcium deposition, and pro-osteogenic protein expression in the aortic valve. Maximum aortic valve cusp separation, as judged by echocardiography, was not altered. During an additional 6 months of hypercholesterolemia, superoxide levels, valvular lipid deposition, and myofibroblast activation remained elevated. Furthermore, calcium deposition and pro-osteogenic gene expression became more pronounced, and the aortic cusp separation decreased from 0.85±0.04 to 0.70±0.04 mm (mean±SE; P<0.05). Rapid normalization of cholesterol levels at 6 months of age (by inducing expression of Cre recombinase) normalized aortic valve superoxide levels, decreased myofibroblast activation, reduced valvular calcium burden, suppressed pro-osteogenic signaling cascades, and prevented reductions in aortic valve cusp separation. CONCLUSIONS-: Collectively, these data indicate that reducing plasma lipid levels by genetic inactivation of the mttp gene in hypercholesterolemic mice with early aortic valve disease normalizes oxidative stress, reduces pro-osteogenic signaling, and halts the progression of aortic valve stenosis.

Original languageEnglish (US)
Pages (from-to)2693-2701
Number of pages9
JournalCirculation
Volume119
Issue number20
DOIs
StatePublished - May 26 2009
Externally publishedYes

Fingerprint

Aortic Diseases
Aortic Valve
Cholesterol
Myofibroblasts
Superoxides
Lipids
Hypercholesterolemia
Hyperlipidemias
Calcium
Oxidative Stress
Aortic Valve Stenosis
Apolipoproteins B
Gene Silencing
Echocardiography
Gene Expression

Keywords

  • Aortic valve stenosis
  • Calcification
  • Free radicals
  • Hypercholesterolemia
  • Valves

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Miller, J. D., Weiss, R. M., Serrano, K. M., Brooks, R. M., Berry, C. J., Zimmerman, K., ... Heistad, D. D. (2009). Lowering plasma cholesterol levels halts progression of aortic valve disease in mice. Circulation, 119(20), 2693-2701. https://doi.org/10.1161/CIRCULATIONAHA.108.834614

Lowering plasma cholesterol levels halts progression of aortic valve disease in mice. / Miller, Jordan D; Weiss, Robert M.; Serrano, Kristine M.; Brooks, Robert M.; Berry, Christopher J.; Zimmerman, Kathy; Young, Stephen G.; Heistad, Donald D.

In: Circulation, Vol. 119, No. 20, 26.05.2009, p. 2693-2701.

Research output: Contribution to journalArticle

Miller, JD, Weiss, RM, Serrano, KM, Brooks, RM, Berry, CJ, Zimmerman, K, Young, SG & Heistad, DD 2009, 'Lowering plasma cholesterol levels halts progression of aortic valve disease in mice', Circulation, vol. 119, no. 20, pp. 2693-2701. https://doi.org/10.1161/CIRCULATIONAHA.108.834614
Miller JD, Weiss RM, Serrano KM, Brooks RM, Berry CJ, Zimmerman K et al. Lowering plasma cholesterol levels halts progression of aortic valve disease in mice. Circulation. 2009 May 26;119(20):2693-2701. https://doi.org/10.1161/CIRCULATIONAHA.108.834614
Miller, Jordan D ; Weiss, Robert M. ; Serrano, Kristine M. ; Brooks, Robert M. ; Berry, Christopher J. ; Zimmerman, Kathy ; Young, Stephen G. ; Heistad, Donald D. / Lowering plasma cholesterol levels halts progression of aortic valve disease in mice. In: Circulation. 2009 ; Vol. 119, No. 20. pp. 2693-2701.
@article{9c3e928c722e442e96503858d2c42f22,
title = "Lowering plasma cholesterol levels halts progression of aortic valve disease in mice",
abstract = "BACKGROUND-: Treatment of hyperlipidemia produces functional and structural improvements in atherosclerotic vessels. However, the effects of treating hyperlipidemia on the structure and function of the aortic valve have been controversial, and any effects could be confounded by pleiotropic effects of hypolipidemic treatment. The goal of this study was to determine whether reducing elevated plasma lipid levels with a {"}genetic switch{"} in Reversa mice (Ldlr-/-/Apob/Mttp/Mx1-Cre) reduces oxidative stress, reduces pro-osteogenic signaling, and retards the progression of aortic valve disease. METHODS AND RESULTS-: After 6 months of hypercholesterolemia, Reversa mice exhibited increases in superoxide, lipid deposition, myofibroblast activation, calcium deposition, and pro-osteogenic protein expression in the aortic valve. Maximum aortic valve cusp separation, as judged by echocardiography, was not altered. During an additional 6 months of hypercholesterolemia, superoxide levels, valvular lipid deposition, and myofibroblast activation remained elevated. Furthermore, calcium deposition and pro-osteogenic gene expression became more pronounced, and the aortic cusp separation decreased from 0.85±0.04 to 0.70±0.04 mm (mean±SE; P<0.05). Rapid normalization of cholesterol levels at 6 months of age (by inducing expression of Cre recombinase) normalized aortic valve superoxide levels, decreased myofibroblast activation, reduced valvular calcium burden, suppressed pro-osteogenic signaling cascades, and prevented reductions in aortic valve cusp separation. CONCLUSIONS-: Collectively, these data indicate that reducing plasma lipid levels by genetic inactivation of the mttp gene in hypercholesterolemic mice with early aortic valve disease normalizes oxidative stress, reduces pro-osteogenic signaling, and halts the progression of aortic valve stenosis.",
keywords = "Aortic valve stenosis, Calcification, Free radicals, Hypercholesterolemia, Valves",
author = "Miller, {Jordan D} and Weiss, {Robert M.} and Serrano, {Kristine M.} and Brooks, {Robert M.} and Berry, {Christopher J.} and Kathy Zimmerman and Young, {Stephen G.} and Heistad, {Donald D.}",
year = "2009",
month = "5",
day = "26",
doi = "10.1161/CIRCULATIONAHA.108.834614",
language = "English (US)",
volume = "119",
pages = "2693--2701",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "20",

}

TY - JOUR

T1 - Lowering plasma cholesterol levels halts progression of aortic valve disease in mice

AU - Miller, Jordan D

AU - Weiss, Robert M.

AU - Serrano, Kristine M.

AU - Brooks, Robert M.

AU - Berry, Christopher J.

AU - Zimmerman, Kathy

AU - Young, Stephen G.

AU - Heistad, Donald D.

PY - 2009/5/26

Y1 - 2009/5/26

N2 - BACKGROUND-: Treatment of hyperlipidemia produces functional and structural improvements in atherosclerotic vessels. However, the effects of treating hyperlipidemia on the structure and function of the aortic valve have been controversial, and any effects could be confounded by pleiotropic effects of hypolipidemic treatment. The goal of this study was to determine whether reducing elevated plasma lipid levels with a "genetic switch" in Reversa mice (Ldlr-/-/Apob/Mttp/Mx1-Cre) reduces oxidative stress, reduces pro-osteogenic signaling, and retards the progression of aortic valve disease. METHODS AND RESULTS-: After 6 months of hypercholesterolemia, Reversa mice exhibited increases in superoxide, lipid deposition, myofibroblast activation, calcium deposition, and pro-osteogenic protein expression in the aortic valve. Maximum aortic valve cusp separation, as judged by echocardiography, was not altered. During an additional 6 months of hypercholesterolemia, superoxide levels, valvular lipid deposition, and myofibroblast activation remained elevated. Furthermore, calcium deposition and pro-osteogenic gene expression became more pronounced, and the aortic cusp separation decreased from 0.85±0.04 to 0.70±0.04 mm (mean±SE; P<0.05). Rapid normalization of cholesterol levels at 6 months of age (by inducing expression of Cre recombinase) normalized aortic valve superoxide levels, decreased myofibroblast activation, reduced valvular calcium burden, suppressed pro-osteogenic signaling cascades, and prevented reductions in aortic valve cusp separation. CONCLUSIONS-: Collectively, these data indicate that reducing plasma lipid levels by genetic inactivation of the mttp gene in hypercholesterolemic mice with early aortic valve disease normalizes oxidative stress, reduces pro-osteogenic signaling, and halts the progression of aortic valve stenosis.

AB - BACKGROUND-: Treatment of hyperlipidemia produces functional and structural improvements in atherosclerotic vessels. However, the effects of treating hyperlipidemia on the structure and function of the aortic valve have been controversial, and any effects could be confounded by pleiotropic effects of hypolipidemic treatment. The goal of this study was to determine whether reducing elevated plasma lipid levels with a "genetic switch" in Reversa mice (Ldlr-/-/Apob/Mttp/Mx1-Cre) reduces oxidative stress, reduces pro-osteogenic signaling, and retards the progression of aortic valve disease. METHODS AND RESULTS-: After 6 months of hypercholesterolemia, Reversa mice exhibited increases in superoxide, lipid deposition, myofibroblast activation, calcium deposition, and pro-osteogenic protein expression in the aortic valve. Maximum aortic valve cusp separation, as judged by echocardiography, was not altered. During an additional 6 months of hypercholesterolemia, superoxide levels, valvular lipid deposition, and myofibroblast activation remained elevated. Furthermore, calcium deposition and pro-osteogenic gene expression became more pronounced, and the aortic cusp separation decreased from 0.85±0.04 to 0.70±0.04 mm (mean±SE; P<0.05). Rapid normalization of cholesterol levels at 6 months of age (by inducing expression of Cre recombinase) normalized aortic valve superoxide levels, decreased myofibroblast activation, reduced valvular calcium burden, suppressed pro-osteogenic signaling cascades, and prevented reductions in aortic valve cusp separation. CONCLUSIONS-: Collectively, these data indicate that reducing plasma lipid levels by genetic inactivation of the mttp gene in hypercholesterolemic mice with early aortic valve disease normalizes oxidative stress, reduces pro-osteogenic signaling, and halts the progression of aortic valve stenosis.

KW - Aortic valve stenosis

KW - Calcification

KW - Free radicals

KW - Hypercholesterolemia

KW - Valves

UR - http://www.scopus.com/inward/record.url?scp=67249120424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67249120424&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.108.834614

DO - 10.1161/CIRCULATIONAHA.108.834614

M3 - Article

C2 - 19433756

AN - SCOPUS:67249120424

VL - 119

SP - 2693

EP - 2701

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 20

ER -